Phase Ib trial combining rapid determination of drug-drug interaction (DDI) followed by a dose finding period to assess safety and preliminary efficacy of fimepinostat plus venetoclax in patients with aggressive B-cell lymphoma Meeting Abstract


Authors: Phillips, T. J.; De Vos, S.; Westin, J.; Barta, S. K.; Cohen, J. B.; Patel, K.; Smith, S. M.; Pagel, J. M.; Kansra, V.; Grayson, D.; Younes, A.; Batlevi, C. L.
Abstract Title: Phase Ib trial combining rapid determination of drug-drug interaction (DDI) followed by a dose finding period to assess safety and preliminary efficacy of fimepinostat plus venetoclax in patients with aggressive B-cell lymphoma
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual Conference
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368303276
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.8056
Notes: Meeting Abstract: 8056 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Connie Wing-Ching Lee Batlevi
    177 Batlevi
  2. Anas Younes
    320 Younes